Genetic immunizationApplying recombinant DNA technology in the immune system to develop new vaccines

Current Opinion in Drug Discovery and Development

Volumn 2, Issue 2, 1999, Pages 118-128

  Barry, Michael A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; B CELL LYMPHOMA VACCINE; CANCER VACCINE; CMV GENE THERAPY; CYTOMEGALOVIRUS VACCINE; DNA VACCINE; GENEVAX VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; PLASMID DNA; PLASMODIUM FALCIPARUM CSP DNA VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ARTICLE; BREAST TUMOR; CLINICAL TRIAL; COLORECTAL CANCER; CYTOMEGALOVIRUS; EBOLA VIRUS; GENE THERAPY; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNIZATION; INFLUENZA; INFLUENZA VIRUS; NONHODGKIN LYMPHOMA; PROSTATE CANCER;

EID: 0032892652     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Tang D, DeVit M, Johnston SA: Genetic immunization is a simple method for eliciting an immune response. Nature (1992) 356:152-154.
2. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Feigner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A, Hawe LA, Leander KR, Martinez D, Perry HC, Shiver JW, Montgomery DL, Liu MA: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (1993) 259:1745-1749.
3. Hariharan MJ, Driver DA, Townsend K, Brumm D, Polo JM, Belli BA, Catton DJ, Hsu D, Mittelstaedt D, McCormack JE, Karavodin L, Dubensky TWJ, Chang SM, Banks TA: DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector. J Virol (1998) 72:950-958.
4. Colombage G, Hall R, Pavy M, Lobigs M: DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology (1998) 250:151-163.
5. Sizemore DR, Branstrom AA, Sadoff JC: Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science (1995) 270:299-302.
6. Barry MA, Barry ME, Johnston SA: Production of monoclonal antibodies by genetic immunization. Biotechniques (1994) 16:616-619.
7. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL: DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA (1993) 90:11478-11482.
8. Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC: Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. \//ro/ogy(1994) 199:132-140.
9. Conry RM, LoBuglio AF, Kantor J, Schlom J, Loechel F, Moore SE, Sumerel LA, Barlow DL, Abrams S, Curiel DT: Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res (1994) 54:1164-1168.
10. Raychaudhuri S, Rock KL: Fully mobilizing host defense: Building better vaccines. Nature 8/otec/7/io/(1998) 16:10251031.
11. Cohen AD, Boyer JD, Weiner DB: Modulating the immune response to genetic immunization. FASEB J (1998) 12:1611-1626.
12. Donnelly JJ, Ulmer JB, Shiver JW, LJu MA: DNA vaccines. Ann Rev Immunol (1997) 15:617-648.
13. Johnston SA, Sykes KF, Barry MA: DNA-based vaccines: Extending the technology. In: New generation vaccines. Levine M (Ed). Marcel Dekker Inc. New York (1997) 1-8.
14. MacGregor RR, Boyer JD, Ugen KE, Lacy KE, Gluckman SJ, Bagarazzi ML, Chattergoon MA, Baine Y, Higgins TJ, Ciccarelli RB, Coney LR, Ginsberg RS, Weiner DB: First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host response. J Infect Dis (1998) 178:92-100.
15. Calarota S, Bratt G, Nordlund S, Hinkula J, Leandersson AC, Sandström E, Wahren B: Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancer (1998) 351:1320-1325.
16. Wang R, Doolan DL, Le TP, Hedstrom RC, Coonan KM, Charoenvit Y, Jones TR, Hobart P, Margalith M, Ng J, Weiss WR, Sedegah M, de Taisne C, Norman JA, Hoffman SL: Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science (1998) 282:476-480.
17. Xu L, Sanchez A, Yang ZY, Zaki SR, Nabel EG, Nichol ST, Nabel GJ: Immunization for Ebola virus infection. Nat Med (1998)4:37-42.
18. Donnelly JJ, Friedman A, Martinez D, Montgomery DL, Shiver JW, Motzel SL, Ulmer JB, Liu MA: Preclinical efficacy of a prototype DNA vaccine:. Enhanced protection against antigenic drift in influenza virus. Nat Med (1995]11:583-587.
19. Denis O, Tanghe A, Palfliet K, Jurion F, van den Berg TP, Vanonckelen A, Ooms J, Saman E, Ulmer JB, Content J, Huygen K: Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4 and CDS Tcell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect Immun (1998)66:1527-1533.
20. Doolan DL, Sedegah M, Hedstrom RC, Hobart P, Charoenvit Y, Hoffman SL: Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CDS' cell-, Interferon y-, and nitric oxidedependent immunity. J Exp Med (1996) 183:1739-1746.
21. Xiang Z, Ertl HCJ: Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity (1995) 2:129135.
22. Kim JJ, Trivedi NN, Nottingham LK, Morrison L, Tsai A, Hu Y, Mahalingam S, Dang K, Ahn L, Doyle NK, Wilson DM, Chattergoon MA, Chalian AA, Boyer JD, Agadjanyan MG, Weiner DB: Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur J Immunol (1998) 28:1089-1103.
23. Barry MA, Lai WC, Johnston SA: Protection against mycoplasma infection using expression library immunization: A general approach to vaccine development. Nature (1995) 377:632-635.
24. Johnston SA, Barry MA: Genetic to genomic vaccination. Vaccine (1996) 15:808-809.
25. Albert! E, Acosta A, Sarmiento ME, Hidalgo C, Vidai T, Fachado A, Fönte L, Izquierdo L, Infante JF, Finlay CM, Sierra G: Specific cellular and humoral immune response in Balb/c mice immunised with an expression genomic library of Trypanosoma cruzi. Vaccine (1998) 16:608-612.
26. Hoffman SL, Rogers WO, Carucci DJ, Venter JC: From genomics to vaccines: malaria as a model system [comment]. NatMed(1998) 4:1351-1353.
27. Pertmer TM, Eisenbraun MD, McCabe D, Prayaga SK, Fuller DH, Haynes JR: Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine (1995) 13:1427-1430.
28. Xiang ZQ, Spitalnik SL, Cheng J, Erikson J, Wojczyk B, Ertl HCJ: Immune responses to nucleic acid vaccines to rabies virus. Virology (1995) 209:569-579.
29. Manthorpe M, Comefert-Jensen F, Hartikka J, Felgner J, Rundell A, Margalith M, Dwarki V: Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum Gene Trier (1993) 4:419-431.
30. Inamine JM, Ho KG, Laechel S, Hu PC: Evidence that TGA is read as a tryptophan codon rather than as a stop codon by Mycoplasma pneumoniae, Mycoplasma genitalium, and Mycoplasma gallisepticum. J8acferio/(1990) 172:504-506.
31. Stemmer WPC: Rapid evolution of a protein in vitro by DNA shuffling. Nature (1994) 370:389-391.
32. Haas J, Park EC, Seed B: Codon usage limitation in the expression of HIV-1 envelope glycoprotein. CurrB/b/(1996) 6:315-324.
33. Andre S, Seed B, Eberle J, Schraut W, Bultmann A, Haas J: Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J Virol (1998) 72:1497-1503.
34. Crameri A, Whitehom EA, Täte E, Stemmer WPC: Improved green fluorescent protein by molecular evolution using DNA shuffling. Nature Biotechnol (1996) 14:315-318.
35. Lu S, Wyatt R, Richmond JF, Mustafa F, Wang S, Montefiori DC, Sodroski J, Robinson HL: Immunogenicity of DNA vaccine expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions. AIDS Res Hum Retroviruses (1998) 14:151-155.
36. Major ME, Vitvitski L, Mink MA, Schleef M, Whalen RG, Trépo C, Inchauspé G: DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J V/ro/(1995) 69:5798-5805.
37. Fu TM, Ulmer JB, Caulfield MJ, Deck RR, Friedman A, Wang S, ü'u X, Donnelly JJ, Liu MA: Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mo/Merf(1997) 3:362-371.
38. Haddad D, Liljeqvist S, Stahl S, Andersson l, Perlmann P, Berzins K, Ahlborg N: Comparative study of DNA-based immunization vectors: Effect of secretion signals on the antibody responses in mice. FEMS Immunol Med Microbiol (1997)18:193-202.
39. Inchauspé G, Vitvitski L, Major ME, Jung G, Spengler U, Maisonnas M, Trepo C: Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: Comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell Biol (1997) 16:185-195.
40. Johnson ES, Bartel B, Seufert W, Varshavsky A: Ubiquitin as a degradation signal. EMBO J(1992) 11:497-505.
41. Blake N, Lee S, Redchenko I, Thomas W, Steven N, Leese A, Steigerwald-Mullen P, Kurilla MG, Frappier L, Rickinson A: Human CDST cell responses to EBV EBNA1: HLA Class I Presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity (1997) 7:791-802.
42. Hengel H, Koopmann JO, Rohr T, Muranyi W, Goulmy E, Hammerting GJ, Koszinowski UH, Momburg F: A viral ERresident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity (1997) 6:623-632.
43. Varshavsky A: The N-end rule: functions, mysteries, uses. Pros NatlAcadSci USA (1996) 93:12142-12149.
44. Tobery TW, Siliciano RF: Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J Exp Med (1997)185:909-920.
45. Rodriguez F, Zhang J, Whitton JL: DNA immunization: Ubiquitination of a viral protein enhances cytotoxic Tlymphocyte induction and antiviral protection but abrogates antibody induction. J V/ro/(1997) 71:8497-8503.
46. Fu TM, Guan L, Friedman A, Ulmer JB, Liu MA, Donnelly JJ: Induction of MHC class l-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens. Vaccine (1998) 16:1711-1717.
47. Xiong S, Gertoni M, Zanetti M: Engineering vaccines with heterologous B and T cell epitopes using immunoglobulin genes. Nat Biotechnol (1997) 15:882-886.
48. Boyle JS, Brady JL, Lew AM: Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature (1998) 392:408-411.